ICON Public Company Investor Relations Material
Latest events
Q2 2025
ICON Public Company
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ICON Public Limited Company
Access all reports
ICON Public Limited Company is a global provider of clinical research and development services to the pharmaceutical, biotechnology, and medical device industries. The company offers a broad range of outsourced services, including clinical trial management, data analytics, regulatory support, and laboratory services. ICON works with clients to facilitate the development and approval of new medical treatments and therapies, supporting clinical trials from early-phase research through to post-market studies. The company's expertise spans multiple therapeutic areas and geographies. The company is headquartered in Dublin, Ireland, and its shares are listed on the NASDAQ.
Key slides for ICON Public Limited Company
Q2 2025
ICON Public Limited Company
43rd Annual J.P. Morgan Healthcare Conference 2025
ICON Public Limited Company
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
ICLR
Country
🇺🇸 United States